People: Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

95.35USD
3:48pm EST
Price Change (% chg)

$2.52 (+2.71%)
Prev Close
$92.83
Open
$94.10
Day's High
$95.45
Day's Low
$93.61
Volume
243,226
Avg. Vol
427,224
52-wk High
$95.45
52-wk Low
$71.50

Search Stocks

Doliveux, Roch 

Brief Biography

Dr. Roch Doliveux, DVM, is Independent Director of Stryker Corp., since June 21, 2010. He served as Chief Executive Officer and Chairman of the Executive Committee of UCB S.A., a global biopharmaceutical company, since 2005. Prior thereto, he was Chief Executive Officer of Pierre Fabre Pharmaceuticals and President of Schering-Plough International, a subsidiary of Schering-Plough Corporation.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kevin Lobo

8,436,920

William Jellison

2,813,360

Lonny Carpenter

2,186,100

David Floyd

2,828,020

Timothy Scannell

3,004,480

Ramesh Subrahmanian

3,196,050
As Of 30 Dec 2013
Search Stocks